In this respect, it has to be recalled that the newcomer review investigation referred to in recital 2 concluded that no individual treatment could be granted to any of the four Chinese companies involved in the said investigation.
Det skal i den forbindelse erindres, at det som led i den undersøgelse for nytilkomne, som er omhandlet i betragtning 2, konkluderedes, at ingen af de fire kinesiske selskaber, der var omfattet af nævnte undersøgelse, kunne opnå individuel behandling.